Publications by authors named "Laura Algeri"

Claim this Profile
E
Exploring Barriers to Inclusivity: Systematic Analysis of Exclusion Criteria and Potential Bias in Clinical Cancer Trials for Psychiatric and Neurological Conditions in European Protocols.
Margherita Dahò, Veronica Coppini, Maria Vittoria Ferrari, Giulia Ferraris, Virginia Sanchini, Laura Algeri

Psychooncology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe?
Lorenzo Gervaso, Davide Ciardiello, Rivadavio Antunes Oliveira, Michele Borghesani, Lorenzo Guidi, Laura Algeri

J Immunother Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous thromboembolism in pancreatic neuroendocrine neoplasm: a cohort study.
Lorenzo Gervaso, Alice Laffi, Aurora Gaeta, Sara Gandini, Laura Boldrini, Laura Algeri

Res Pract Thromb Haemost· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study.
Lorena Incorvaia, Dario De Biase, Margherita Nannini, Elena Fumagalli, Bruno Vincenzi, Laura Algeri

Oncologist· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal treatment for resectable neuroendocrine carcinoma of the cervix.
Carmine Valenza, Francesca Spada, Francesco Multinu, Lavinia Benini, Michele Borghesani, Laura Algeri

Endocr Relat Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab.
Lorena Incorvaia, Alessandra Dimino, Laura Algeri, Chiara Brando, Luigi Magrin

Front Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors.
Alessandra Dimino, Chiara Brando, Laura Algeri, Valerio Gristina, Erika Pedone

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of gemcitabine for the treatment of classic Kaposi's sarcoma without visceral involvement.
Giuseppe Badalamenti, Lorena Incorvaia, Laura Algeri, Annalisa Bonasera, Alessandra Dimino

Ther Adv Med Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Not all 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs).
Lorena Incorvaia, Giuseppe Badalamenti, Daniele Fanale, Bruno Vincenzi, Ida De Luca, Laura Algeri

Ther Adv Med Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?
Daniele Fanale, Lorena Incorvaia, Giuseppe Badalamenti, Ida De Luca, Laura Algeri

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A "Lymphocyte MicroRNA Signature" as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming.
Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, Chiara Brando, Marco Bono, Laura Algeri

Cancers (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis